Fycompa Brand Extension: Eisai Launched FYCOMPA® (perampanel) Oral Suspension
Posted on17 Jun 2016
Comments0
Fycompa Brand Extension: Eisai Launched FYCOMPA® (perampanel) Oral Suspension Brand: FYCOMPA® Molecule: perampanel. Indication: FYCOMPA (perampanel) is indicated as adjunctive therapy for... Read More
Fycompa got Expanded Approval for Primary Generalized Tonic-Clonic Seizure
The U.S. FDA this week expanded the indication of Eisai Inc.’s perampanel (Fycompa) as adjunctive therapy for the treatment of primary generalized... Read More